Effects of <i>Anchomanes difformis</i> on Inflammation, Apoptosis, and Organ Toxicity in STZ-Induced Diabetic Cardiomyopathy

Persistent hyperglycemia is known to cause enhanced generation of reactive oxygen species in diabetes. Several inflammatory cytokines are induced by oxidative stress, and their release also leads to increased oxidative stress; this makes oxidative stress one of the important factors in the developme...

Full description

Bibliographic Details
Main Authors: Toyin D. Alabi, Novel N. Chegou, Nicole L. Brooks, Oluwafemi O. Oguntibeju
Format: Article
Language:English
Published: MDPI AG 2020-02-01
Series:Biomedicines
Subjects:
Online Access:https://www.mdpi.com/2227-9059/8/2/29
_version_ 1811296963236200448
author Toyin D. Alabi
Novel N. Chegou
Nicole L. Brooks
Oluwafemi O. Oguntibeju
author_facet Toyin D. Alabi
Novel N. Chegou
Nicole L. Brooks
Oluwafemi O. Oguntibeju
author_sort Toyin D. Alabi
collection DOAJ
description Persistent hyperglycemia is known to cause enhanced generation of reactive oxygen species in diabetes. Several inflammatory cytokines are induced by oxidative stress, and their release also leads to increased oxidative stress; this makes oxidative stress one of the important factors in the development of chronic inflammation and other immune responses. These have been implicated in the development of diabetic complications such as nephropathy and cardiomyopathy. <i>Anchomanes difformis</i> has been shown to possess antioxidant and anti-inflammatory potentials. The present study investigated the immunomodulatory potential and the antiapoptotic ability of <i>Anchomanes difformis</i> to ameliorate heart toxicity and injury in type II diabetes. Two weeks of fructose (10%) administration followed by single intraperitoneal injection of streptozotocin (40 mg/kg) were used to induce type II diabetes in male Wistar rats. Leaf extract (aqueous) of <i>Anchomanes difformis</i> (200 and 400 mg/kg) was administered orally for six weeks. Blood glucose concentrations and body weights before and after interventions were determined. Interleukin (IL)-1&#946;, IL-6, IL-10, IL-18, monocyte chemoattractant protein 1 (MCP-1), and tumor necrosis factor alpha (TNF&#945;) were measured in the heart homogenates. Catalase (CAT), superoxide dismutase (SOD), total protein, oxygen radical absorbance capacity (ORAC), ferric reducing antioxidant power (FRAP), thiobarbituric acid reactive substances (TBARS), and heart-type fatty acid-binding protein (H-FABP) levels were determined. Expressions of transcription factors (Nrf 2 and NFkB/p65) and apoptotic markers were also investigated in the heart. <i>Anchomanes</i> <i>difformis</i> administration reduced pro-inflammatory cytokines, increased anti-inflammatory markers, and enhanced antioxidant defense in the heart of diabetic treated animals. <i>Anchomanes</i> <i>difformis</i> is a new, promising therapeutic agent that can be explored for the treatment of pathological conditions associated with immune responses and will be a useful tool in the management of associated diabetic complications.
first_indexed 2024-04-13T05:57:02Z
format Article
id doaj.art-add9fba5f47c4ad58dc0efc1de01c4ff
institution Directory Open Access Journal
issn 2227-9059
language English
last_indexed 2024-04-13T05:57:02Z
publishDate 2020-02-01
publisher MDPI AG
record_format Article
series Biomedicines
spelling doaj.art-add9fba5f47c4ad58dc0efc1de01c4ff2022-12-22T02:59:36ZengMDPI AGBiomedicines2227-90592020-02-01822910.3390/biomedicines8020029biomedicines8020029Effects of <i>Anchomanes difformis</i> on Inflammation, Apoptosis, and Organ Toxicity in STZ-Induced Diabetic CardiomyopathyToyin D. Alabi0Novel N. Chegou1Nicole L. Brooks2Oluwafemi O. Oguntibeju3Phytomedicine &amp; Phytochemistry Group, Oxidative Stress Research Centre, Department of Biomedical Sciences, Faculty of Health and Wellness Sciences, Cape Peninsula University of Technology, Bellville 7535, South AfricaDST-NRF Centre of Excellence for Biomedical Tuberculosis Research, South African Medical Research Council Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, P.O. Box 241, Cape Town 8000, South AfricaFaculty of Health and Wellness Sciences, Cape Peninsula University of Technology, Cape Town 8000, South AfricaPhytomedicine &amp; Phytochemistry Group, Oxidative Stress Research Centre, Department of Biomedical Sciences, Faculty of Health and Wellness Sciences, Cape Peninsula University of Technology, Bellville 7535, South AfricaPersistent hyperglycemia is known to cause enhanced generation of reactive oxygen species in diabetes. Several inflammatory cytokines are induced by oxidative stress, and their release also leads to increased oxidative stress; this makes oxidative stress one of the important factors in the development of chronic inflammation and other immune responses. These have been implicated in the development of diabetic complications such as nephropathy and cardiomyopathy. <i>Anchomanes difformis</i> has been shown to possess antioxidant and anti-inflammatory potentials. The present study investigated the immunomodulatory potential and the antiapoptotic ability of <i>Anchomanes difformis</i> to ameliorate heart toxicity and injury in type II diabetes. Two weeks of fructose (10%) administration followed by single intraperitoneal injection of streptozotocin (40 mg/kg) were used to induce type II diabetes in male Wistar rats. Leaf extract (aqueous) of <i>Anchomanes difformis</i> (200 and 400 mg/kg) was administered orally for six weeks. Blood glucose concentrations and body weights before and after interventions were determined. Interleukin (IL)-1&#946;, IL-6, IL-10, IL-18, monocyte chemoattractant protein 1 (MCP-1), and tumor necrosis factor alpha (TNF&#945;) were measured in the heart homogenates. Catalase (CAT), superoxide dismutase (SOD), total protein, oxygen radical absorbance capacity (ORAC), ferric reducing antioxidant power (FRAP), thiobarbituric acid reactive substances (TBARS), and heart-type fatty acid-binding protein (H-FABP) levels were determined. Expressions of transcription factors (Nrf 2 and NFkB/p65) and apoptotic markers were also investigated in the heart. <i>Anchomanes</i> <i>difformis</i> administration reduced pro-inflammatory cytokines, increased anti-inflammatory markers, and enhanced antioxidant defense in the heart of diabetic treated animals. <i>Anchomanes</i> <i>difformis</i> is a new, promising therapeutic agent that can be explored for the treatment of pathological conditions associated with immune responses and will be a useful tool in the management of associated diabetic complications.https://www.mdpi.com/2227-9059/8/2/29<i>anchomanes difformis</i>apoptosiscardiomyopathydiabetesglibenclamideinflammationoxidative stress
spellingShingle Toyin D. Alabi
Novel N. Chegou
Nicole L. Brooks
Oluwafemi O. Oguntibeju
Effects of <i>Anchomanes difformis</i> on Inflammation, Apoptosis, and Organ Toxicity in STZ-Induced Diabetic Cardiomyopathy
Biomedicines
<i>anchomanes difformis</i>
apoptosis
cardiomyopathy
diabetes
glibenclamide
inflammation
oxidative stress
title Effects of <i>Anchomanes difformis</i> on Inflammation, Apoptosis, and Organ Toxicity in STZ-Induced Diabetic Cardiomyopathy
title_full Effects of <i>Anchomanes difformis</i> on Inflammation, Apoptosis, and Organ Toxicity in STZ-Induced Diabetic Cardiomyopathy
title_fullStr Effects of <i>Anchomanes difformis</i> on Inflammation, Apoptosis, and Organ Toxicity in STZ-Induced Diabetic Cardiomyopathy
title_full_unstemmed Effects of <i>Anchomanes difformis</i> on Inflammation, Apoptosis, and Organ Toxicity in STZ-Induced Diabetic Cardiomyopathy
title_short Effects of <i>Anchomanes difformis</i> on Inflammation, Apoptosis, and Organ Toxicity in STZ-Induced Diabetic Cardiomyopathy
title_sort effects of i anchomanes difformis i on inflammation apoptosis and organ toxicity in stz induced diabetic cardiomyopathy
topic <i>anchomanes difformis</i>
apoptosis
cardiomyopathy
diabetes
glibenclamide
inflammation
oxidative stress
url https://www.mdpi.com/2227-9059/8/2/29
work_keys_str_mv AT toyindalabi effectsofianchomanesdifformisioninflammationapoptosisandorgantoxicityinstzinduceddiabeticcardiomyopathy
AT novelnchegou effectsofianchomanesdifformisioninflammationapoptosisandorgantoxicityinstzinduceddiabeticcardiomyopathy
AT nicolelbrooks effectsofianchomanesdifformisioninflammationapoptosisandorgantoxicityinstzinduceddiabeticcardiomyopathy
AT oluwafemiooguntibeju effectsofianchomanesdifformisioninflammationapoptosisandorgantoxicityinstzinduceddiabeticcardiomyopathy